β³ Fetching live dividend data...
Home βΊ Calculator βΊ ELTP Dividend Calculator 2026
Elite Pharmaceuticals, Inc. Β· OTC
Price: $0.34 Β· Annual div: $2.00/share Β· Frequency: quarterly Β· Payout ratio: 50% Β· Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in ELTP β $332.95M in 10 years Β· $158,474.18/month
Elite Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and manufacture of oral, controlled-release products and generic pharmaceuticals. The company operates in two segments, Abbreviated New Drug Applications for Generic Products and New Drug Applications for Branded Products. It owns, licenses, and contract manufactures various generic and oral dose pharmaceuticals products, such as Phentermine HCl 37.5mg tablets for the treatment of bariatrics under Adipex-P brand; Phendimetrazine Tartrate 35mg tablets for bariatrics under the Bontril brand; Naltrexone HCl 50mg tablets for the treatment of pains under the Revia brand; and Isradipine 2.5mg and 5mg capsules for cardiovascular diseases. The company also provides Oxycodone HCl immediate release 5mg, 10mg, 15mg, 20mg, and 30mg tablets for pains under Roxycodone brand; Trimipramine Maleate Immediate Release antidepressant capsules under the Surmontil brand; Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate Immediate Release tablets for central nervous system diseases under the Adderall brand, as well as Dantrolene Sodium capsules for muscle relaxant under the Dantrium brand; SequestOX, an immediate release Oxycodone with Naltrexone; Loxapine Succinate capsules for treating antipsychotic under the brand Loxapine; Acetaminophen and Codeine Phosphate for the management of mild to moderate pain; and antibiotic products. In addition, it manufactures controlled-release products on a contract basis for third parties in the areas of pain, allergy, bariatric, and infection. Further, the company is developing a range of abuse deterrent opioid products. The company was incorporated in 1997 and is headquartered in Northvale, New Jersey.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. Β· Privacy Policy
Ready to invest? Open ELTP position with:
Real after-tax yield depends on where you live and how you hold ELTP.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| πΊπΈ Roth IRA / 401k | 0% | 588.24% | 585.44% | $58,824 / yr |
| πΊπΈ US Taxable (15%) β | 15% | 500.00% | 497.20% | $50,000 / yr |
| πΊπΈ US Taxable (20%) | 20% | 470.59% | 467.79% | $47,059 / yr |
| π¬π§ UK ISA | 0% | 588.24% | 585.44% | $58,824 / yr |
| π¬π§ UK Taxable | 8.75% | 536.77% | 533.97% | $53,677 / yr |
| π¨π¦ TFSA | 0% | 588.24% | 585.44% | $58,824 / yr |
| π¨π¦ CA Taxable | 25% | 441.18% | 438.38% | $44,118 / yr |
| π¦πΊ Super (pension) | 15% | 500.00% | 497.20% | $50,000 / yr |
| π¦πΊ AU Taxable | 30% | 411.77% | 408.97% | $41,177 / yr |
| π©πͺ DE Taxable | 26.375% | 433.09% | 430.29% | $43,309 / yr |
| π«π· FR Taxable | 30% | 411.77% | 408.97% | $41,177 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr Β· πΊπΈ US Taxable (15%) Β· static projection (no growth assumed).
ELTP pays quarterly β 4 times per year. Next ex-div: TBD.
How ELTP compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024β2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for ELTP sourced from FMP /financial-growth endpoint β real data, not estimates.
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| M-Exempt | 2026-01-09 | 2,500,000 | $0.03 | $75.0K | ||
| M-Exempt | 2026-01-09 | 2,500,000 | $0.03 | $75.0K | ||
| Sale | 2025-10-02 | 800,000 | $0.62 | $499.2K | ||
| M-Exempt | 2025-08-25 | 2,500,000 | $0.03 | $75.0K | ||
| M-Exempt | 2025-08-25 | 2,500,000 | $0.03 | $75.0K | ||
| Sale | 2025-08-22 | 500,000 | $0.52 | $262.1K | ||
| Buy | 2025-07-10 | 16,366 | $0.59 | $9.6K | ||
| Sale | 2025-07-08 | 200,000 | $0.58 | $115.8K | ||
| M-Exempt | 2025-07-03 | 2,500,000 | $0.03 | $75.0K | ||
| M-Exempt | 2025-07-03 | 2,500,000 | $0.03 | $75.0K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores β lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the ELTP dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer β
Real users. No sign-up required to leave a review.
βFinally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.β
βI've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly β $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.β
βReally solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.β
βAs someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.β
βThe Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.β
Reviews reflect users' personal experiences. Not financial advice.
Leave a review β